Cite
Lavanderos MA, Cayún JP, Roco Á, et al. Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients. Front Pharmacol. 2019;10:206doi: 10.3389/fphar.2019.00206.
Lavanderos, M. A., Cayún, J. P., Roco, �. �., Sandoval, C., Cerpa, L., Rubilar, J. C., Cerro, R., Molina-Mellico, S., Celedón, C., Cerda, B., García-Martín, E., Agúndez, J. A. G., Acevedo, C., Peña, K., Cáceres, D. D., Varela, N. M., & Quiñones, L. A. (2019). Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients. Frontiers in pharmacology, 10206. https://doi.org/10.3389/fphar.2019.00206
Lavanderos, María A, et al. "Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients." Frontiers in pharmacology vol. 10 (2019): 206. doi: https://doi.org/10.3389/fphar.2019.00206
Lavanderos MA, Cayún JP, Roco Á, Sandoval C, Cerpa L, Rubilar JC, Cerro R, Molina-Mellico S, Celedón C, Cerda B, García-Martín E, Agúndez JAG, Acevedo C, Peña K, Cáceres DD, Varela NM, Quiñones LA. Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients. Front Pharmacol. 2019 Mar 08;10:206. doi: 10.3389/fphar.2019.00206. eCollection 2019. PMID: 30914949; PMCID: PMC6421934.
Copy
Download .nbib